Page 156 WHO - Guidelines on the pharmacological treatment of persisting pain in children with medical illness

90. Taricco M et al. Pharmacological interventions for spasticity following spinal cord injury. Cochrane
Database of Systematic Reviews, 2000, (2):CD001131.
91. Shakespeare D, Boggild M, Young CA. Anti-spasticity agents for multiple sclerosis. Cochrane
Database of Systematic Reviews, 2003, (4):CD001332.
92. United Nations Convention on the Rights of the Child (1989). New York, NY, United Nations, 1989
(UN General Assembly Document A/RES/44/25).

93. The right to the highest attainable standard of health: 11/08/2000. Substantive issues arising in
the implementation of the international covenant on economic, social and cultural rights. General
comment No. 14 (2000) (article 12 of the International Covenant on Economic, Social and Cultural
Rights). In: Twenty-second session of the Committee on Economic and Social Rights, Geneva, 25
April–12 May 2000, Agenda item 3. New York, NY, United Nations, 2000 (E/C, 12/2000/4).
94. Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol amending the
Single Convention on Narcotic Drugs, 1961. New York, NY, United Nations, 1972 (http://www.
incb.org/pdf/e/conv/convention_1961_en.pdf, accessed 23 January 2011).
95. Ensuring balance in national policies on controlled substances: guidance for availability and
accessibility of controlled medicines. Geneva, World Health Organization, 2011. (available on the
web in 14 languages. http://www.who.int/medicines/areas/quality_safety/guide_nocp_sanend/en/
index.html, accessed 9 September 2011).

96. De Lima L et al. Potent analgesics are more expensive for patients in developing countries: a
comparative study. Journal of Pain & Palliative Care Pharmacotherapy, 2004, 18:59–70.
97. De Lima L. Opioid availability in Latin America as a global problem: a new strategy with regional
and national effects. Journal of Palliative Medicine, 2004, 7:97–103.
98. Tediosi F at al. Access to medicines and out of pocket payments for primary care: evidence from
family medicines users and in rural Tajikistan. BMC Health Services Research, 2008, 8:109. (http://
www.biomedcentral.com/content/pdf/1472-6963-8-109.pdf, accessed 9 September 2011).
99. Leive A, Xu K. Coping with out-of-pocket health payments: empirical evidence from 15 African
countries. Bulletin of the World Health Organization (BLT), 2008, 86:849–860.
100. Manzi F et al. Out-of-pocket payments for under-five health care in rural southern Tanzania.
Health Policy and Planning, 2005, 20(Suppl. 1):i85–i93.
101. Practical guide for procurement planning and management of strategic public health supplies.
Washington, DC, Pan American Health Organization, 2006.
102. Babaley M. Les défis dans les systèmes d’approvisionnement et de distribution des médicaments
et autres produits de santé en Afrique : une cartographie pour sensibiliser les financeurs et les
acteurs. ReMed, 2009, 41:10–18.

103. Phillips CJ et al. Prioritising pain in policy making: the need for a whole systems perspective.
Health Policy, 2008, 88:166–175.
104. Phillips CJ. The real cost of pain management. Anaesthesia, 2001, 56:1031–1033.
105. Loeser JD. Economic implications of pain management. Acta Anaesthesiologica Scandinavica,
1999, 43:957–959.
106. Smith BH et al. The impact of chronic pain in the community. Family Practice, 2001, 18:292–299.

153 <